Abbreviated or not abbreviated? Is it the right question?

and cause of death among elderly chronic obstructive disease patients after first admission to hospital. Respiration 1997;64:281–4. 7 Zielinski J, MacNee W, Wedzicha J, et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis 1997;52:43–7. 8 Hansell AL. Lies, damned lies and mortality statistics? Thorax 2006;61:923–4. 9 Sin DD, Man SFP. Cooling the fire within: inhaled corticosteroids and cardiovascular mortality in COPD. Chest 2006;130:629–30. 10 Macie C, Wooldrage K, Manfreda J, et al. Inhaled corticosteroids and mortality in COPD. Chest 2006;130:640–6. 11 Price LC, Lowe D, Hosker HSR, et al, on behalf of the British Thoracic Society and the Royal College of Physicians Clinical Effectiveness Evaluation Unit (CEEu). UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax 2006;61:837–42. 12 Mannino DM. Women and chronic obstructive pulmonary disease: does sex influence survival? Am J Respir Crit Care Med 2006;174:488–9. 13 Machado ML, Krishman JA, Buist AS, et al. Sex differences in survival in oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:524–9. 14 Ramsey SD, Hobbs FDR. Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease. Proc Am Thorac Soc 2006;3:635–40. 15 McGarvey LP, John M, Anderson JA, et al. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007;62:411–15. 16 Sin DD, Wu L, Man SFP. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005;127:1952–9. 17 Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313:711–5. 18 Curkendall SM, Deluise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada Cardiovascular Disease in COPD patients. Ann Epidemiol 2006;16:63–70. 19 Soyseth V, Brekke PH, Smith P, et al. Statin use is associated with reduced mortality in COPD. Eur Respir J 2007;29:279–83. 20 Lauer MS, Blackstone EH, Young JB, et al. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 1999;34:618–20.